Enfusion, Inc. (ENFN)

NYSE: ENFN · IEX Real-Time Price · USD
11.76
-0.22 (-1.84%)
Jan 27, 2023, 4:00 PM EST - Market closed

Stock Price Forecast

According to 12 stock analysts, the average 12-month stock price forecast for Enfusion stock is $13.06, which predicts an increase of 11.05%. The lowest target is $10.1 and the highest is $14.7. On average, analysts rate Enfusion stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $10.1 $13.06 $14.28 $14.7
Change -14.12% +11.05% +21.43% +25.00%

Analyst Ratings

The average analyst rating for Enfusion stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Aug '22Sep '22Oct '22Nov '22Dec '22Jan '23
Strong Buy 555444
Buy 433333
Hold 444555
Sell 000000
Strong Sell 000000
Total 131212121212

Financial Forecast

Revenue This Year
152.82M
from 111.70M
Increased by 36.81%
Revenue Next Year
193.65M
from 152.82M
Increased by 26.72%
EPS This Year
0.09
from -2.26
EPS Next Year
0.18
from 0.09
Increased by 85.16%
Year 201920202021202220232024
Revenue
59.03M79.57M111.70M152.82M193.65M245.50M
Revenue Growth
-
34.79%
40.39%
36.81%
26.72%
26.78%
EPS
---2.260.090.180.30
EPS Growth
----
85.16%
70.23%
No. Analysts ---886

Revenue Forecast

Revenue 202220232024
High 157.5M 204.9M 267.4M
Avg 152.8M 193.7M 245.5M
Low 146.5M 181.3M 230.3M

Revenue Growth

Revenue Growth 202220232024
High
41.0%
34.1%
38.1%
Avg
36.8%
26.7%
26.8%
Low
31.2%
18.6%
18.9%

EPS Forecast

EPS 202220232024
High 0.13 0.23 0.35
Avg 0.09 0.18 0.30
Low 0.07 0.14 0.25

EPS Growth

EPS Growth 202220232024
High -
144.0%
97.7%
Avg -
85.2%
70.2%
Low -
46.0%
45.4%
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.